OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $133,207 | -25.2% | 40,612 | -41.2% | 0.00% | – |
| Q1 2023 | $178,116 | +102.8% | 69,037 | +46.2% | 0.00% | – |
| Q4 2022 | $87,844 | +104.3% | 47,228 | +103.6% | 0.00% | – |
| Q3 2022 | $43,000 | -17.3% | 23,200 | -3.3% | 0.00% | – |
| Q2 2022 | $52,000 | -75.9% | 24,000 | -65.2% | 0.00% | – |
| Q1 2022 | $216,000 | -47.7% | 68,965 | -46.3% | 0.00% | – |
| Q4 2021 | $413,000 | -23.9% | 128,425 | -20.4% | 0.00% | – |
| Q3 2021 | $543,000 | -9.8% | 161,424 | +4.7% | 0.00% | – |
| Q2 2021 | $602,000 | -44.6% | 154,213 | -42.9% | 0.00% | – |
| Q1 2021 | $1,086,000 | +108.8% | 269,968 | +19.8% | 0.00% | – |
| Q4 2020 | $520,000 | -54.5% | 225,305 | +13.3% | 0.00% | – |
| Q3 2020 | $1,142,000 | +146.7% | 198,910 | +216.8% | 0.00% | – |
| Q2 2020 | $463,000 | +193.0% | 62,780 | +64.8% | 0.00% | – |
| Q4 2019 | $158,000 | +92.7% | 38,088 | +162.0% | 0.00% | – |
| Q3 2018 | $82,000 | -59.8% | 14,537 | -25.4% | 0.00% | – |
| Q2 2017 | $204,000 | – | 19,493 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |